The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02• GutAlive®: Microbiota Collection and Transport in Anaerobic Conditions• From Discovery to Disease Prevention: How the Biose–Siolta Partnership is Advancing a New Generation of Live Biotherapeutics• A pioneering gut bacterium passes Europe’s food-safety review under the EU Novel Food Regulation•

Month: April 2024

Lallemand Health Solutions and dsm-firmenich: New Partnership for Early-Life Synbiotic Solutions
Biotics and Supplements

Lallemand Health Solutions and dsm-firmenich: New Partnership for Early-Life Synbiotic Solutions

APR 24, 2024
Millions of gamers advance biomedical research
Pharma & Human Health

Millions of gamers advance biomedical research

APR 23, 2024
SNIPR Biome receives funding from CARB-X for advancement of SNIPR001 into clinical trials in haematological cancer patients
Clinical & Manufacturing

SNIPR Biome receives funding from CARB-X for advancement of SNIPR001 into clinical trials in haematological cancer patients

APR 22, 2024
MRM Health Reports Safety and Positive Efficacy Data in Pouchitis in Phase 2a Clinical Study with MH002
Clinical & Manufacturing

MRM Health Reports Safety and Positive Efficacy Data in Pouchitis in Phase 2a Clinical Study with MH002

APR 16, 2024
AI powered “digital twin” models the infant microbiome
Pharma & Human Health

AI powered “digital twin” models the infant microbiome

APR 15, 2024
New enzymatic cocktail can kill tuberculosis-causing mycobacteria
Infectious Disease & AMR

New enzymatic cocktail can kill tuberculosis-causing mycobacteria

APR 15, 2024
Advancing Cardiovascular and Renal Health: The Collaboration between BioMe and Bacthera on BM109
Pharma & Human Health

Advancing Cardiovascular and Renal Health: The Collaboration between BioMe and Bacthera on BM109

APR 10, 2024
Nestlé translates analysis of pet’s gut microbiome data into tailored nutrition and supplement recommendation
Animal Health

Nestlé translates analysis of pet’s gut microbiome data into tailored nutrition and supplement recommendation

APR 5, 2024
EnteroBiotix Completes £27m Financing Round & Initiates Phase 2 Study in Patients with IBS
Clinical & Manufacturing

EnteroBiotix Completes £27m Financing Round & Initiates Phase 2 Study in Patients with IBS

APR 4, 2024